News

The upgraded version of the DNA sequencing system is referred to as C2. The PacBio RS reveals new biological insights by incorporating novel, single molecule sequencing techniques, advanced

The communications technology solution platform will bring together existing but isolated communications and healthcare IT infrastructure investments, the company said. The platform will leverage existing hospital and clinical

The plant, which is a joint venture between the SA government, through Pelchem, and Lonza, will be established near Pelindaba in Gauteng, the Times Live said. Ketlaphela, once

Recombinant and microbial P450 and glycosylating technology have been developed for accessing metabolites at mg to 100s grams scale, the company said. These enzymes, which resemble human systems,

As per the agreement, Tris will use its proprietary technology and will develop up to six new drug applications (NDAs), on behalf of Vernalis. Tris will undertake and

Uceris is a locally acting corticosteroid that utilizes proprietary MMX multi-matrix system technology to enable controlled release and distribution of budesonide throughout the length of the colon. The

The primary objective of the study is to evaluate the safety and tolerability of SGX201 and assess the preliminary efficacy of SGX201 for prevention of symptoms of acute

Tony Sedgwick has joined the company in September 2011 and has extensive experience from European life science companies including more than fifteen years at Roche. Prior to joining

Tadalafil is an FDA-approved drug used as treatment for male erectile dysfunction (ED). The active drug ingredient is not listed on the label for these products. Tadafil could